Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2007-05-10 | Rakesh K. Jain, Ph.D. (56), 30 Rowes Wharf, Boston, MA 02110 Director (since 1991), Steele Lab, Department of Radiation Oncology at Massachusetts General Hospital; A.W. Cook Professor of Radiation Oncology (since 1991) at Harvard Medical School; Ad hoc Consultant/Scientific Advisory Board member (various times since 2002) for pharmaceutical/biotech companies; Ad hoc Consultant (since 2004) for Gershon Lehman Group; Advisory Committee Member (since 2004) of Department of Biotechnology, Government of India. |
| 2008-05-05 | Rakesh K. Jain, Ph.D. (57), Trustee of HQH and HQL (since 2007); Member of each Fund's Governance Committee; Member of each Fund's Nominating Committee; Total Compensation from both Funds and Fund Complex Paid to Trustees: $11,500. |
| 2009-05-01 | Rakesh K. Jain, Ph.D. (58), Trustee of HQH and HQL (since 2007); Member of each Fund's Governance Committee; Member of each Fund's Nominating Committee; Compensation: $46,000 total from both Funds. |
| 2010-04-27 | Rakesh K. Jain, Ph.D. (59), Trustee, HQH and HQL (since 2007); Member of each Fund's Governance Committee; Member of each Fund's Nominating Committee; Compensation: $46,000 total from both Funds. |
| 2011-06-08 | Dr. Rakesh Jain is the Andrew Werk Cook Professor of Tumor Biology in the Department of Radiation Oncology at Harvard Medical School and the Director of the Edwin L. Steele Laboratory of Tumor Biology at Massachusetts General Hospital, providing the Fund with a valuable perspective on emerging life sciences technologies. He serves on the Governance and Nominating Committees of the Funds. ... For the fiscal year ended September 30, 2010 the Fund paid its Independent Trustees an annual fee of $20,000. Additionally, the Fund currently pays each Independent Trustee $500 for each Board and Committee meeting attended in person and $250 for each Board and Committee meeting attended by telephone. Currently, the Chairman of the Board of Trustees, the Chairman of the Audit Committee and the Chairman of the Valuation Committee of the Fund receives an additional annual fee of $2,500. Currently, the Chairman of the Nominating Committee and the Chairman of the Governance Committee of the Fund receives an additional annual fee of $1,250. ... Compensation Table ... Rakesh K. Jain, Ph.D. ... Total Compensation ... $48,000 |
| 2012-04-30 | Rakesh K. Jain, Ph.D.: Dr. Rakesh Jain is the Andrew Werk Cook Professor of Tumor Biology in the Department of Radiation Oncology at Harvard Medical School and the Director of the Edwin L. Steele Laboratory of Tumor Biology at Massachusetts General Hospital, providing the Fund with a valuable perspective on emerging life sciences technologies. He serves on the Governance and Nominating Committees of the Funds. |
| 2013-04-25 | Rakesh K. Jain, Ph.D.: Dr. Rakesh Jain is the Andrew Werk Cook Professor of Tumor Biology in the Department of Radiation Oncology at Harvard Medical School and the Director of the Edwin L. Steele Laboratory of Tumor Biology at Massachusetts General Hospital, providing the Fund with a valuable perspective on emerging life sciences technologies. He serves on the Governance Committee and is Chairman of the Nominating Committee of the Fund. ... Compensation Table For the fiscal year ended September 30, 2012 ... Rakesh K. Jain, Ph.D. $23,500 + $23,500 = $47,000 total compensation. |
| 2014-04-30 | Rakesh K. Jain, Ph.D.: Dr. Rakesh Jain is the Andrew Werk Cook Professor of Tumor Biology in the Department of Radiation Oncology at Harvard Medical School and the Director of the Edwin L. Steele Laboratory of Tumor Biology at Massachusetts General Hospital, providing the Fund with a valuable perspective on emerging life sciences technologies. ... He serves on the Governance and Nominating Committee of the Fund. ... The members of the Committee are Mr. Bonney, Dr. Jain and Ms. Stebbins. ... The members of the Fund's QLCC are Dr. Jain, Mr. Pohotsky and Mr. Reardon. Mr. Reardon is the Chairman of the Fund's QLCC. ... Compensation Table ... Rakesh K. Jain, Ph.D. ... Total Compensation ... $48,000. |
| 2015-04-20 | Rakesh K. Jain, Ph.D. (64) 100 Federal Street, 19th Floor,Boston MA 02110 Trustee of HQH, HQL and THQ; Member of each Fund's Governance and Nominating and Qualified Legal Compliance Committees. Compensation Table: Total Compensation from All Funds in Fund Complex Paid to Trustees $68,500. |
| 2016-04-18 | Rakesh K. Jain, Ph.D.: Dr. Rakesh Jain is the Andrew Werk Cook Professor of Tumor Biology in the Department of Radiation Oncology at Harvard Medical School and the Director of the Edwin L. Steele Laboratory of Tumor Biology at Massachusetts General Hospital, providing each Fund with a valuable perspective on emerging life sciences technologies. Dr. Jain co-founded XTuit Pharmaceuticals, Inc. in 2012, where he also serves as a board member. He serves on the Governance and Nominating Committee of each Fund. |
| 2017-04-18 | Rakesh K. Jain, Ph.D.: Dr. Rakesh Jain is the Andrew Werk Cook Professor of Tumor Biology in the Department of Radiation Oncology at Harvard Medical School and the Director of the Edwin L. Steele Laboratory of Tumor Biology at Massachusetts General Hospital, providing each Fund with a valuable perspective on emerging life sciences technologies. He serves on the Governance and Nominating Committee of each Fund. ... Compensation Table ... Rakesh K. Jain, Ph.D. ... Total Compensation from All Funds in Fund Complex Paid to Trustees $78,000. |
| 2018-04-18 | Rakesh K. Jain, Ph.D.: Dr. Rakesh Jain is the Andrew Werk Cook Professor of Tumor Biology in the Department of Radiation Oncology at Harvard Medical School and the Director of the Edwin L. Steele Laboratory of Tumor Biology at Massachusetts General Hospital, providing each Fund with a valuable perspective on emerging life sciences technologies. Dr. Jain co-founded XTuit Pharmaceuticals, Inc. in 2012, where he also serves as a board member. He serves on the Governance and Nominating Committee of each Fund. |
| 2020-04-14 | Dr. Jain co-founded XTuit Pharmaceuticals, Inc. in 2012, where he also served as a board member until 2018. He serves on the Governance and Nominating Committee of each Fund. ... For the fiscal year ended September 30, 2019, each Fund paid an annual fee of $15,000 to its Independent Trustees and the Chairman of the Board receives an additional annual fee of $5,000. Additionally, each Fund paid each Independent Trustee $1,000 for each Board and $750 for each Committee meeting attended in person and $250 for each Board and Committee meeting attended by telephone. The Chairman of the Audit Committee, the Valuation Committee and the Governance and Nominating Committee of each Fund each received an additional annual fee of $2,000. ... Rakesh K. Jain, Ph.D. total compensation $78,000. |
| 2021-04-13 | Rakesh K. Jain, Ph.D.: Dr. Rakesh Jain is the A. W. Cook Professor of Radiation Oncology (Tumor Biology) at Harvard Medical School... He serves on the Governance and Nominating Committee of each Fund. The members of each Fund's QLCC are Dr. Jain, Mr. Pohotsky and Mr. Reardon. Mr. Reardon is the Chairman of each Fund's QLCC. Compensation Table shows Rakesh K. Jain total compensation from all funds as $82,000. |
| 2022-04-12 | Rakesh K. Jain, Ph.D.: Dr. Jain is the A. W. Cook Professor of Radiation Oncology at Harvard Medical School. He serves as the Chairman of the Governance and Nominating Committee of each Fund. For the fiscal year ended September 30, 2021, his total compensation was $92,250. |
| 2023-04-11 | Dr. Jain is the A. W. Cook Professor of Radiation Oncology (Tumor Biology) at Harvard Medical School and the Director of the E. L. Steele Laboratories of Tumor Biology at Massachusetts General Hospital. He serves as the Chairman of the Governance and Nominating Committee of each Fund. The members of each Fund's QLCC are Dr. Jain and Mr. Kent. Mr. Kent is the Chairman of each Fund's QLCC. For the fiscal year ended September 30, 2022, the Independent Trustees as a group received $2,098 from HQH, $2,037 from THQ and $1,140 from THW for reimbursed expenses. The following table sets forth information regarding compensation of the Trustees and Executive Officer by each Fund for the fiscal year ended September 30, 2022... Rakesh K. Jain, Ph.D. $112,417 total compensation. |
| 2023-07-10 | Rakesh K. Jain, Ph.D. received $28,104 from each Fund for the fiscal year ended September 30, 2022, totaling $112,417. |
| Filing Date | Source Excerpt |
|---|---|
| 2007-05-10 | Rakesh K. Jain, Ph.D. (56), 30 Rowes Wharf, Boston, MA 02110 Director (since 1991), Steele Lab, Department of Radiation Oncology at Massachusetts General Hospital; A.W. Cook Professor of Radiation Oncology (since 1991) at Harvard Medical School; Ad hoc Consultant/Scientific Advisory Board member (various times since 2002) for pharmaceutical/biotech companies; Ad hoc Consultant (since 2004) for Gershon Lehman Group; Advisory Committee Member (since 2004) of Department of Biotechnology, Government of India. |
| 2008-05-05 | Rakesh K. Jain, Ph.D. (57), Trustee of HQH and HQL (since 2007); Member of each Fund's Governance Committee; Member of each Fund's Nominating Committee; Total Compensation from both Funds and Fund Complex Paid to Trustees: $11,500. |
| 2009-05-01 | Rakesh K. Jain, Ph.D. (58), Trustee of HQH and HQL (since 2007); Member of each Fund's Governance Committee; Member of each Fund's Nominating Committee; Compensation: $46,000 total from both Funds. |
| 2010-04-27 | Rakesh K. Jain, Ph.D. (59), Trustee, HQH and HQL (since 2007); Member of each Fund's Governance Committee; Member of each Fund's Nominating Committee; Compensation: $46,000 total from both Funds. |
| 2011-06-08 | Rakesh K. Jain, Ph.D.: Dr. Rakesh Jain is the Andrew Werk Cook Professor of Tumor Biology in the Department of Radiation Oncology at Harvard Medical School and the Director of the Edwin L. Steele Laboratory of Tumor Biology at Massachusetts General Hospital, providing the Fund with a valuable perspective on emerging life sciences technologies. He serves on the Governance and Nominating Committees of the Funds. |
| 2012-04-30 | Rakesh K. Jain, Ph.D.: Dr. Rakesh Jain is the Andrew Werk Cook Professor of Tumor Biology in the Department of Radiation Oncology at Harvard Medical School and the Director of the Edwin L. Steele Laboratory of Tumor Biology at Massachusetts General Hospital, providing the Fund with a valuable perspective on emerging life sciences technologies. He serves on the Governance and Nominating Committees of the Funds. |
| 2013-04-25 | Rakesh K. Jain, Ph.D.: Dr. Rakesh Jain is the Andrew Werk Cook Professor of Tumor Biology in the Department of Radiation Oncology at Harvard Medical School and the Director of the Edwin L. Steele Laboratory of Tumor Biology at Massachusetts General Hospital, providing the Fund with a valuable perspective on emerging life sciences technologies. He serves on the Governance Committee and is Chairman of the Nominating Committee of the Fund. ... Compensation Table ... Rakesh K. Jain, Ph.D. ... Total Compensation from both Funds in Fund Complex Paid to Trustees $47,000. |
| 2014-04-30 | Rakesh K. Jain, Ph.D. (63) 2 Liberty Square,9th Floor, Boston MA 02109 Trustee of HQH and HQL; Member of each Fund's Governance and Nominating and Qualified Legal Compliance Committees. ... The members of the Committee are ... Dr. Jain ... The Fund's QLCC are Dr. Jain ... For the fiscal year ended September 30, 2013 ... Rakesh K. Jain, Ph.D. ... Total Compensation from both Funds in Fund Complex Paid to Trustees $48,000. |
| 2015-04-20 | Rakesh K. Jain, Ph.D. (64) 100 Federal Street, 19th Floor,Boston MA 02110 Trustee of HQH, HQL and THQ; Member of each Fund's Governance and Nominating and Qualified Legal Compliance Committees. Compensation: $68,500 |
| 2016-04-18 | Rakesh K. Jain, Ph.D.: Dr. Rakesh Jain is the Andrew Werk Cook Professor of Tumor Biology in the Department of Radiation Oncology at Harvard Medical School and the Director of the Edwin L. Steele Laboratory of Tumor Biology at Massachusetts General Hospital, providing each Fund with a valuable perspective on emerging life sciences technologies. Dr. Jain co-founded XTuit Pharmaceuticals, Inc. in 2012, where he also serves as a board member. He serves on the Governance and Nominating Committee of each Fund. Rakesh K. Jain, Ph.D. (65) 100 Federal Street, 19th Floor, Boston MA 02110: Trustee of HQH, HQL, THQ and THW; Member of each Fund's Governance and Nominating and Qualified Legal Compliance Committees. Compensation: $80,918. |
| 2017-04-18 | Rakesh K. Jain, Ph.D.: Dr. Rakesh Jain is the Andrew Werk Cook Professor of Tumor Biology in the Department of Radiation Oncology at Harvard Medical School and the Director of the Edwin L. Steele Laboratory of Tumor Biology at Massachusetts General Hospital, providing the Fund with a valuable perspective on emerging life sciences technologies. Dr. Jain co-founded XTuit Pharmaceuticals, Inc. in 2012, where he also serves as a board member. He serves on the Governance and Nominating Committee of the Fund. Prior to joining Harvard, he was professor of chemical engineering at Columbia University and Carnegie Mellon University. Dr. Jain is regarded as a pioneer in the fields of tumor biology, drug delivery, in vivo imaging and bioengineering. Dr. Jain has authored more than 600 publications. He serves on advisory panels to government, industry and academia, and has served or continues to serve on editorial advisory boards of twenty journals, including Journal of Clinical Oncology and Nature Reviews Clinical Oncology. He has received more than 70 major awards and lectureships, including the United States National Medal of Science, a Guggenheim Fellowship, the Humboldt Senior Scientist Award, the National Cancer Institute's Research Career Development Award and Outstanding Investigator Grant, the Academic Scientist of the Year Award from the Pharmaceutical Achievements Awards, the Distinguished Service Award from Nature Biotechnology and the Innovator Award from the DoD Breast Cancer Program. He is a member of all three branches of US National Academies 6 the Institute of Medicine, the National Academy of Engineering and the |
| 2018-04-18 | Rakesh K. Jain, Ph.D.: Dr. Rakesh Jain is the Andrew Werk Cook Professor of Tumor Biology in the Department of Radiation Oncology at Harvard Medical School and the Director of the Edwin L. Steele Laboratory of Tumor Biology at Massachusetts General Hospital, providing the Fund with a valuable perspective on emerging life sciences technologies. Dr. Jain co-founded XTuit Pharmaceuticals, Inc. in 2012, where he also serves as a board member. He serves on the Governance and Nominating Committee of the Fund. Compensation Table: Rakesh K. Jain, Ph.D. $18,125; Total Compensation $71,750. |
| 2020-04-14 | Dr. Jain co-founded XTuit Pharmaceuticals, Inc. in 2012, where he also served as a board member until 2018. He serves on the Governance and Nominating Committee of each Fund. ... For the fiscal year ended September 30, 2019, each Fund paid an annual fee of $15,000 to its Independent Trustees and the Chairman of the Board receives an additional annual fee of $5,000. Additionally, each Fund paid each Independent Trustee $1,000 for each Board and $750 for each Committee meeting attended in person and $250 for each Board and Committee meeting attended by telephone. The Chairman of the Audit Committee, the Valuation Committee and the Governance and Nominating Committee of each Fund each received an additional annual fee of $2,000. ... Rakesh K. Jain, Ph.D. total compensation $78,000. |
| 2021-04-13 | Rakesh K. Jain, Ph.D.: Dr. Rakesh Jain is the A. W. Cook Professor of Radiation Oncology at Harvard Medical School... He serves on the Governance and Nominating Committee and the Qualified Legal Compliance Committee of each Fund. For the fiscal year ended September 30, 2020, the Independent Trustees as a group received $82,000 for Dr. Jain. |
| 2022-04-12 | Dr. Jain serves as the Chairman of the Governance and Nominating Committee of the Fund. Compensation Table shows total compensation of $92,250. |
| 2023-04-11 | Dr. Jain is the A. W. Cook Professor of Radiation Oncology at Harvard Medical School. He serves as the Chairman of the Governance and Nominating Committee and is a member of the Qualified Legal Compliance Committee. Compensation Table shows total compensation from all funds in fund complex paid to Dr. Jain is $112,417. |
Data sourced from SEC filings. Last updated: 2026-02-03